-
Réseaux structurels et fonctionnels dans les troubles du spectre de l’autisme et le syndrome de l’X fragile
https://braincanada.ca/funded-grants/réseaux-structurels-et-fonctionnels-dans-les-troubles-du-spectre-de-l-autisme-et-le-syndrome-de-l-x-fragileMany childhood disorders, such as Autism Spectrum Disorder (ASD) or Fragile X Syndrome (FXS), are a result of abnormal growth and connections throughout the brain, rather than being caused by some specific pathology, such as a tumour. Project Overview Many childhood disorders, such as Autism...
-
Safety and feasibility of focused ultrasound-enabled liquid biopsy in patients with brain tumours
https://braincanada.ca/funded-grants/safety-and-feasibility-of-focused-ultrasound-enabled-liquid-biopsy-in-patients-with-brain-tumoursNeed for project: Neuropathological diagnoses of brain tumours require invasive neurosurgical biopsies that carry a risk of morbidity or mortalityto patients. Project Overview Need for project: Neuropathological diagnoses of brain tumours require invasive neurosurgical biopsies that carry a risk of...
-
Screen Time and the Developing Brain: Research, Benefits, Risks, and Policy
https://braincanada.ca/about/news-updates/screen-time-and-the-developing-brain-research-benefits-risks-and-policyThe panel discussion , organized by Brain Canada and hosted by the Canadian Science Policy Centre, focused on the impact of impacts of digital technology, or screen time, on children and youth and the policy opportunities to address these impacts. Key points included the importance of co-viewing...
-
Screening of glioblastoma oncometabolite by ultrafast solid phase microextraction approach
https://braincanada.ca/funded-grants/screening-of-glioblastoma-oncometabolite-by-ultrafast-solid-phase-microextraction-approachNeed for project: The rate of success of a given treatment for brain cancer is dependent on early diagnosis followed by qualification for surgery, which to date remains as the course of treatment with the highest survival rate for brain cancer patients. Project Overview Need for project: The rate...
-
Screens are changing young brains. Canada needs a plan
https://braincanada.ca/about/news-updates/screens-are-changing-young-brains-canada-needs-a-planDr. Emma Duerden is an associate professor and Canada Research Chair in neuroscience and learning disorders – applied psychology at Western University. Dr. Franco Vaccarino is professor emeritus at the University of Guelph and former president and vice chancellor. Alison Palmer is the evaluation and...
-
Season, Light Exposure and Serotonin Transporter Binding
https://braincanada.ca/funded-grants/season-light-exposure-and-serotonin-transporter-bindingThe serotonin transporter (5-HTT) is a protein that clears extracellular serotonin from the synapses and depletion of serotonin is associated with depressive symptoms. Project Overview The serotonin transporter (5-HTT) is a protein that clears extracellular serotonin from the synapses and depletion...
-
Seeing The Invisible Disability
https://braincanada.ca/about/news-updates/seeing-the-invisible-disabilityRob Staffen recommends the MyBrainPacer app developed by St Joseph’s Health Care London, Ont. (www.mybrainpacer. a) to regulate activities during the recovery period after experiencing a TBI. “There are resources out there,” he says, “but they need to be better known.” Rob Staffen was standing at...
-
Selection of DNA Aptamers for Inhibition of Protein Aggregation in ALS
https://braincanada.ca/funded-grants/selection-of-dna-aptamers-for-inhibition-of-protein-aggregation-in-alsThe fight against ALS is made extremely challenging due to its largely unknown origin in most patients. Project Overview The fight against ALS is made extremely challenging due to its largely unknown origin in most patients. This is the case for sporadic ALS, which accounts for up to 90% of all ALS...
-
Selective knockdown of misfolded SOD1 as a therapy for amyotrophic lateral sclerosis
https://braincanada.ca/funded-grants/selective-knockdown-of-misfolded-sod1-as-a-therapy-for-amyotrophic-lateral-sclerosisIn some cases of ALS, it is clear that specific inherited genetic changes (called mutations) can not only cause the disease, but can do so by creating a protein (the end product of genes that actually does a function in our cells) that has an abnormal, toxic function resulting in motor neuron...
-
Selectively Targeting ERK Signaling to Treat Fragile X Syndrome and Autism
https://braincanada.ca/funded-grants/selectively-targeting-erk-signaling-to-treat-fragile-x-syndrome-and-autismAutism is one of the most prevalent neurodevelopmental disorders in Canada. It has a profound impact on the health, wellness and socioeconomic wellbeing of the patients and their families. Project Overview Autism is one of the most prevalent neurodevelopmental disorders in Canada. It has a profound...